Howard Marks - Oaktree Capital Management
Holding/activity history for Bellevue Life Sciences Acqui (BLAC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q3 | 0 | 0 | Sell 100.00% | 0.03 | |
| 2023 Q2 | 175,000 | 0.03 | $10.26 | ||
| 2023 Q1 | 175,000 | 0.02 | Buy | 0.02 | $10.10 |